Dr. Richard Zuckerman MD, MPH, Associate Professor of Medicine, came to Dartmouth in 2005 after completing his fellowship at the University of Washington in Seattle. He is the Director of the Transplant Infectious Disease Program at Dartmouth, a service that he has developed since his arrival. He has established an active inpatient and outpatient service for infectious disease care of immunocompromised hosts from the hematology and solid organ transplant services. He is involved in teaching and research in both stem cell transplantation and in solid organ transplantation. He has done research evaluating pre-autologous stem cell transplant predictors of immune response to pneumococcal vaccination. In an extension of his fellowship research, Dr. Zuckerman is also involved in international clinical trials of the interactions between HSV and HIV infections. He is also involved in the evaluation of immunologic reconstitution after solid organ transplantation, including evaluating biomarkers to predict optimal immune suppression regimens. Dr. Zuckerman is involved in teaching medical students and actively mentoring multiple fellows and residents in research projects, and is currently director of the ID fellowship program at DHMC.
Dr. Bryan Marsh received his MD from the University of Chicago, and then completed his training with residency and fellowship at Dartmouth-Hitchcock Medical Center. He joined the faculty of the Section of IDIH in 1996 and is now an Associate Professor of Medicine. Dr. Marsh's main interest is in the care of people living with HIV/AIDS, but his clinical activities also include consultation in general infectious diseases as well as on the transplant consultation service. He is the Medical Director of the HIV Program and the Ryan White Part C Program, the Director of the Comprehensive Antimicrobial Program, and since January 2007 the Acting and then permanent Chief of the Section of IDIH.
Dr. Lisa Adams received her MD at Dartmouth Medical School and has subsequently focused her attention on tuberculosis. She has worked on TB both domestically, including as the Director of Surveillance, TB Control Program, New York City Department of Health, and internationally as the consultant to many organizations and countries. She returned to Dartmouth in 2002 and since 2004 has been an Assistant Professor in the Section of Infectious Disease and International Health, the Director of the Global Health Initiative, the director of the DARDAR Pediatric Program, and on the Faculty of the Dartmouth-BU AIDS International Research and Training Program (Fogarty) in collaboration with Muhimbili University College of Health Sciences. She remains a very active international consultant on TB program development. She is the Associate Dean for Global Health at the Giesel School of Medicine at Dartmouth.
Antonia Altomare, DO, MPH is an Assistant Professor of Medicine at the Geisel School of Medicine at Dartmouth and in addition to practicing clinical Infectious Disease also serves as Hospital Epidemiologist and Medical Director of the Collaborative Healthcare-associated Infection Prevention Program and Readiness and Response to Epidemic Threats Committee. Dr. Altomare completed her medical training at the New York College of Osteopathic Medicine and residencies in Internal Medicine and Preventive Medicine, and a fellowship in Infectious Diseases at DHMC. Additionally, she completed her Masters of Public Health at the Dartmouth Institute for Health Policy & Clinical Practice. Her primary interests are quality improvement within infection control, and general infectious disease including immunocompromised hosts and HIV care.
Dr. Michael Calderwood obtained his MD from the University of Chicago, followed by residency at Brigham and Women’s Hospital, fellowship in ID at Brigham and Women’s Hospital and Massachusetts General Hospital, and a MPH from the Harvard School of Public Health. Prior to coming to Dartmouth, he was a faculty member at Brigham and Women’s Hospital where he served as the Associate Director of Antimicrobial Stewardship and the Assistant Hospital Epidemiologist, along with being a research investigator in the Therapeutic Research and Infectious Disease Epidemiology group in the Harvard Medical School Department of Population Medicine. He came to Dartmouth in 2016 where he is an Assistant Professor of Medicine and the D-H Regional Hospital Epidemiologist.
His interests include hospital epidemiology, infection prevention, and antimicrobial stewardship. He has had research collaborations with the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, and the Agency for Healthcare Research and Quality. Currently at Dartmouth, he is involved in quality improvement work related to the prevention of central line-associated bloodstream infections, catheter-associated urinary tract infections, C. difficile infections, and surgical site infections. He also has an ongoing interest in antimicrobial stewardship and the critical role that ID physicians play in promoting optimal use of antimicrobial medications..
Dr. Timothy Lahey obtained his MD from Duke University, followed by residency at the University of Utah, fellowship in ID at Beth Israel Deaconess Medical Center and Massachusetts General Hospital, and an MMSc in translational research from Harvard Medical School. He came to Dartmouth in 2005 where he is an Associate Professor of Medicine and has joint appointments in the Departments of Medicine and of Microbiology & Immunology.
His clinical focus is on infections in the immunocompromised host: he holds HIV clinics in Lebanon and Manchester, NH, and rounds on the transplant ID service. Dr. Lahey studies immunity to HIV and tuberculosis including through the DarDar study in Dar es Salaam, Tanzania. Dr. Lahey is also very active in medical school education and the head of the Dartmouth-Hitchcock Bioethics Committee.
Dr. Paul Palumbo obtained his MD at the University of Vermont, followed by residency training at the Medical College of Virginia and Dartmouth-Hitchcock Medical Center and fellowship in pediatric ID at Stanford University. He joined the faculty of Cornell-Weill Medical College followed by UMD-New Jersey Medical School, and joined the Dartmouth faculty as Professor of Medicine and Pediatrics in 2006. Dr. Palumbo's research interests include many aspects of pediatric HIV. He currently is the Vice Chair of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials Network (IMPAACT), and the director of the DARDAR Pediatric Program. At Dartmouth he is the primary pediatric HIV physician, but his clinical activities also include general pediatric ID.
Dr. Jeffrey Parsonnet obtained his MD from NYU School of Medicine. He then did his Medicine residency at Yale-New Haven Hospital and an ID fellowship in the Brigham and Women's/Beth Israel Hospital Combined Program. He came to Dartmouth in 1990, where he is now Professor of Medicine. Dr. Parsonnet is a nationally recognized authority on the epidemiology, pathogenesis, and treatment of toxic shock syndrome (TSS), which he has been studying for the past two decades. Dr. Parsonnet has also been the institutional PI for multiple sponsored clinical studies, mainly dealing with new treatments for staphylococcal infections and septic shock. In addition to his ongoing research, Dr. Parsonnet is an active clinician, in both general ID and HIV medicine, and has spearheaded DHMC's HIV outreach program in Brattleboro, Vermont. He has a special interest in staphylococcal infections and Lyme disease. Dr. Parsonnet directed the ID fellowship program at DHMC from its inception until 2010.
Dr. Surachai Supattapone's education includes obtaining a D.Phil. in Physiology from Oxford University as a Rhodes Scholar, followed by an M.D. and Ph.D. in neuroscience at Johns Hopkins University School of Medicine, where his thesis project identified the inositol trisphosphate (IP3) receptor under the mentorship of Solomon H. Snyder. Dr. Supattapone subsequently completed his residency in Internal Medicine at Massachusetts General Hospital, fellowship in Infectious Diseases at UCSF, and then a post-doctoral fellowship also at UCSF working under the mentorship of Stanley B. Prusiner. In 1998, Dr. Supattapone received both the Burroughs Wellcome Career Development Award and the National Institutes of Health (NIH) physician-scientist (K08) award. He joined the faculty of Dartmouth Medical School in 2001, where he is currently Professor of Biochemistry and of Medicine, and where he and his colleagues are studying the pathogenesis of prion diseases using novel biochemical and genetic model systems.
Dr. Elizabeth Talbot received her MD from Robert Wood Johnson Medical School, University of Medicine and Dentistry of NJ, followed by residency and ID and Global Health fellowship at Duke University Medical Center. She subsequently joined the CDC where she worked five years both domestically in the Epidemic Intelligence Service and as the Team Leader for TB/HIV, International Activities, Div. of TB Elimination) and internationally as the Associate Director for TB/HIV Research, The BOTUSA Project, Botswana. She was assigned to the WHO for policy development for the Global Fund Against AIDS, Tuberculosis and Malaria, and then came to Dartmouth in 2003. Dr. Talbot is currently an Associate Professor of Medicine, and has served as the Deputy State Epidemiologist (DSE) for the State of New Hampshire DHHS. In July, 2007 Dr. Talbot became a consultant for the Foundation for Innovative New Diagnostics (FIND) in Geneva. Her work at DHMC includes consultation on general infectious diseases with a focus on mycobacterial infections, medical director of the Global Health and Travel Clinic, participation in the Collaborative Hospital Infection Prevention Program. She is a key member of the PEPFAR subcontract for healthcare delivery at Les Cayes Haiti, with efforts to improve TB case finding and care. She also consults on pediatric TB control in the Democratic Republic of Congo, Tanzania and Swaziland. She is on the Scientific Committee for the NIH research network, IMPAACT, representing pediatric TB research. Her research activities are primarily on tuberculosis (focused on diagnostics), but she continues to engage in outbreak and epidemiologic investigations in New Hampshire. Examples of ongoing research include operations research of isoniazid preventive therapy for children in Swaziland; translational research of a new rapid culture method in Transylvania Romania, implementation research toward improved delivery of molecular diagnosis of TB among HIV infected persons in Haiti.
Dr. Thomas Taylor received his MD at the University of Colorado, followed by internship and residency at the Beth Israel Hospital, Rheumatology fellowship at the Robert B. Brigham Hospital and Infectious Disease fellowship at the New England Deaconess Hospital. He has been on the faculty of Dartmouth Medical School, with a primary clinical appointment at the White River Junction VA (where he is Chief of both the Rheumatology and Infectious Disease Sections) and a secondary appointment at DHMC. He is currently Associate Professor of Medicine, with appointments in both Infectious Diseases and Rheumatology and continues an active practice in both.
Dr. Ford von Reyn is Professor of Medicine and the Director of the DARDAR International Programs at Dartmouth Medical School. He received his MD from Harvard Medical School, followed by residency and Infectious Disease fellowship at Beth Israel Hospital in Boston and training with the Epidemic Intelligence Service at the Centers for Disease Control. Dr. von Reyn joined the faculty of DMS in 1988 as the Chief of the Section of Infectious Disease and remained in that position until 2007 when he stepped down to focus his work on the DARDAR International Programs and other research activities.
Dr. von Reyn is responsible, among other accomplishments, for the growth of the IDIH Section to its current size, the development of the DH HIV Program, the introduction of antimicrobial management and infection control programs at DH, and the growth of international activities at DMS. In addition, he maintained a very active clinical practice through 2007. He was the acting Chair of the Department of Medicine at DH from 1998-1999 and has been a member or chair of many regional, national and international committees.
Dr. von Reyn's research interests focus primarily on mycobacterial infections and most recently on tuberculosis, with a particular focus on novel vaccines and pertinent immunology. He has built the international collaboration resulting in the many activities of the DARDAR Programs, and remains the Director of these programs.
Dr. Richard Waddell received his D.Sc. from the Netherlands Institute for Health Sciences of the Erasmus University Medical School. He has been at Dartmouth since 1995, currently as a Research Assistant Professor. His major areas of research interest are in tuberculosis and HIV, global infectious disease epidemiology, research ethics, and cancer and environmental epidemiology. Dr. Waddell is also the director for the New Hampshire AIDS Education and Training Center; and is very active in the Dartmouth/Boston University AIDS International Research and Training Program.
Dr. Peter Wright received his MD from Harvard Medical School, followed by training at NIAID and then residency and fellowship at Children's Hospital in Boston. He subsequently had an extensive research career at Vanderbilt (where he was Professor of Pediatrics, Professor of Microbiology and Immunology, Professor of Pathology, and Chief, Division of Pediatric Infectious Disease), and came to Dartmouth part-time (split with Vanderbilt) in July, 2007. In July 2008, he transitioned to full-time at Dartmouth. Dr. Wright's research interests have revolved around viral pathogenesis and vaccine development. In addition, he has provided leadership for a large HIV treatment clinic in Haiti that has become a model of success for antiretroviral therapy in a resource limited setting.
At Dartmouth he heads the development of a Clinical Translational Research Core and has support for the evaluation of novel influenza vaccines. His primary clinical interest in is Pediatric Infectious Disease.